Aprea Therapeutics, Inc. (APRE)
0.815
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 10:01
Aprea Therapeutics Cash from Operations (Annual) : -12.89M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -12.89M |
| December 31, 2024 | -13.56M |
| December 31, 2023 | -12.18M |
| December 31, 2022 | -25.01M |
| December 31, 2021 | -37.69M |
| Date | Value |
|---|---|
| December 31, 2020 | -41.80M |
| December 31, 2019 | -26.71M |
| December 31, 2018 | -15.25M |
| December 31, 2017 | -14.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Zymeworks, Inc. | -33.00M |
| Rhythm Pharmaceuticals, Inc. | -115.68M |
| Onconetix, Inc. | -9.678M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |